A share price of Beta Bionics Inc [BBNX] is currently trading at $16.61, up 13.22%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BBNX shares have gain 10.81% over the last week, with a monthly amount drifted -23.63%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Beta Bionics Inc [NASDAQ: BBNX] stock has seen the most recent analyst activity on February 24, 2025, when Stifel initiated its Buy rating and assigned the stock a price target of $25. Previously, Piper Sandler started tracking the stock with Overweight rating on February 24, 2025, and set its price target to $26. On February 24, 2025, Leerink Partners initiated with a Outperform rating and assigned a price target of $28 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $30 on February 24, 2025. BofA Securities initiated its recommendation with a Buy. Robert W. Baird started tracking with a Neutral rating for this stock on February 20, 2025, and assigned it a price target of $20. In a note dated February 20, 2025, Ladenburg Thalmann initiated an Neutral rating and provided a target price of $20 on this stock.
Beta Bionics Inc experienced fluctuations in its stock price throughout the past year between $13.64 and $24.50. Beta Bionics Inc [NASDAQ: BBNX] shares were valued at $16.61 at the most recent close of the market.
Analyzing the BBNX fundamentals
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.08 points at the first support level, and at 13.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.61, and for the 2nd resistance point, it is at 18.61.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Beta Bionics Inc [NASDAQ:BBNX] is 4.62. Also, the Quick Ratio is 3.99.
Transactions by insiders
Recent insider trading involved Mensinger Mike, Chief Product Officer, that happened on Jan 31 ’25 when 33350.0 shares were purchased. Chief Product Officer, Mensinger Mike completed a deal on Jan 31 ’25 to sell 13.0 shares. Meanwhile, 10% Owner Wellington Hadley Harbor Aggre bought 1.0 million shares on Jan 31 ’25.
